Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Expression of p53 in human leukemic cell lines.

S Kraiss1, R Espig, U Vetter

  • 1Department of Biochemistry, University of Ulm, F.R. Germany.

Leukemia Research
|January 1, 1990
PubMed
Summary

Elevated p53 protein levels in leukemia cells are due to increased stability, not synthesis. These p53 proteins exhibit structural and immunological variations, suggesting a role in human malignancies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Superficial fibromas with CTNNB1 mutation.

Genes, chromosomes & cancer·2024
Same author

[Conventional epiphyseal chondrosarcoma of childhood and adolescence: a case report].

Der Unfallchirurg·2021
Same author

[Tumors with predominantly adipocytic morphology].

Der Pathologe·2019
Same author

[Ewing sarcomas and Ewing-like sarcomas : New aspects].

Der Pathologe·2018
Same author

Coherent modulation up to 100 GBd 16QAM using silicon-organic hybrid (SOH) devices.

Optics express·2018
Same author

[The role of focal adhesions in Ewing's sarcoma].

Der Pathologe·2017

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • The p53 antigen is linked to human malignancies.
  • Understanding p53's role in cancer is crucial.

Purpose of the Study:

  • To analyze the biochemical properties of p53 in acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (ANLL) cell lines.
  • To investigate the stability, oligomerization, and immunological characteristics of p53 in these cancer cells.

Main Methods:

  • Biochemical analysis of p53 in ALL and ANLL cell lines.
  • Assessment of p53 protein levels, stability, and synthesis rates.
  • Investigation of p53 oligomerization and immunological heterogeneity using immunoprecipitation and monoclonal antibodies.

Main Results:

Related Experiment Videos

  • p53 levels were elevated in both ALL and ANLL cell lines compared to normal lymphocytes.
  • Increased p53 levels were attributed to extended protein stability rather than altered synthesis.
  • p53 formed heterogeneous populations of low- and high-molecular weight oligomers.
  • Sequential immunoprecipitation revealed immunologically distinct p53 subsets.

Conclusions:

  • p53 exhibits structural and immunological variability in human tumor-derived cell lines.
  • These findings offer insights into the potential role of p53 in human malignancies.
  • The stability and heterogeneity of p53 may be significant factors in cancer development.